Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |